Antibodies to pre-erythrocytic Plasmodium falciparum antigens and risk of clinical malaria in Kenyan children

Chandy John, Aaron J. Tande, Ann M. Moormann, Peter O. Sumba, David E. Lanar, Xinan M. Min, James W. Kazura

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

Background. IgG antibodies to pre-erythrocytic antigens are involved in prevention of infection and disease in animal models of malaria but have not been associated with protection against disease in human malaria. Methods. Levels of IgG antibodies to circumsporozoite protein (CSP), liver-stage antigen type 1 (LSA-1), and thrombospondin-related adhesive protein (TRAP) were measured in 86 children in a malaria-holoendemic area of Kenya. The children were then monitored for episodes of clinical malaria for 52 weeks. Results. Children with high levels of IgG antibodies to CSP, LSA-1, and TRAP had a decreased risk of clinical malaria (adjusted hazard ratio, 0.29; 95% confidence interval 0.10-0.81; P = .02), a lower incidence of clinical malaria (P = .006), protection from clinical malaria with a parasite level of ≥4000 parasites/μL (P = .03), and a higher hemoglobin level at enrollment (P = .009), compared with children with lower antibody levels. Protection against malaria morbidity was associated primarily with antibodies to CSP and LSA-1. Conclusions. Kenyan children with high levels of IgG antibodies to the pre-erythrocytic antigens CSP, LSA-1, and TRAP have a lower risk of developing clinical malaria than children without high levels of these antibodies. The decreased risk of clinical malaria may be mediated in part by prevention of high-density parasitemia.

Original languageEnglish (US)
Pages (from-to)519-526
Number of pages8
JournalJournal of Infectious Diseases
Volume197
Issue number4
DOIs
StatePublished - Feb 15 2008
Externally publishedYes

Fingerprint

Plasmodium falciparum
Malaria
Antigens
Antibodies
Thrombospondin 1
Immunoglobulin G
Adhesives
Proteins
Liver
Parasites
Animal Disease Models
Parasitemia
Kenya
Hemoglobins
Confidence Intervals
Morbidity
Incidence

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Immunology

Cite this

John, C., Tande, A. J., Moormann, A. M., Sumba, P. O., Lanar, D. E., Min, X. M., & Kazura, J. W. (2008). Antibodies to pre-erythrocytic Plasmodium falciparum antigens and risk of clinical malaria in Kenyan children. Journal of Infectious Diseases, 197(4), 519-526. https://doi.org/10.1086/526787

Antibodies to pre-erythrocytic Plasmodium falciparum antigens and risk of clinical malaria in Kenyan children. / John, Chandy; Tande, Aaron J.; Moormann, Ann M.; Sumba, Peter O.; Lanar, David E.; Min, Xinan M.; Kazura, James W.

In: Journal of Infectious Diseases, Vol. 197, No. 4, 15.02.2008, p. 519-526.

Research output: Contribution to journalArticle

John, Chandy ; Tande, Aaron J. ; Moormann, Ann M. ; Sumba, Peter O. ; Lanar, David E. ; Min, Xinan M. ; Kazura, James W. / Antibodies to pre-erythrocytic Plasmodium falciparum antigens and risk of clinical malaria in Kenyan children. In: Journal of Infectious Diseases. 2008 ; Vol. 197, No. 4. pp. 519-526.
@article{7c8d9f4544574c3dbef2671fb7b50b1b,
title = "Antibodies to pre-erythrocytic Plasmodium falciparum antigens and risk of clinical malaria in Kenyan children",
abstract = "Background. IgG antibodies to pre-erythrocytic antigens are involved in prevention of infection and disease in animal models of malaria but have not been associated with protection against disease in human malaria. Methods. Levels of IgG antibodies to circumsporozoite protein (CSP), liver-stage antigen type 1 (LSA-1), and thrombospondin-related adhesive protein (TRAP) were measured in 86 children in a malaria-holoendemic area of Kenya. The children were then monitored for episodes of clinical malaria for 52 weeks. Results. Children with high levels of IgG antibodies to CSP, LSA-1, and TRAP had a decreased risk of clinical malaria (adjusted hazard ratio, 0.29; 95{\%} confidence interval 0.10-0.81; P = .02), a lower incidence of clinical malaria (P = .006), protection from clinical malaria with a parasite level of ≥4000 parasites/μL (P = .03), and a higher hemoglobin level at enrollment (P = .009), compared with children with lower antibody levels. Protection against malaria morbidity was associated primarily with antibodies to CSP and LSA-1. Conclusions. Kenyan children with high levels of IgG antibodies to the pre-erythrocytic antigens CSP, LSA-1, and TRAP have a lower risk of developing clinical malaria than children without high levels of these antibodies. The decreased risk of clinical malaria may be mediated in part by prevention of high-density parasitemia.",
author = "Chandy John and Tande, {Aaron J.} and Moormann, {Ann M.} and Sumba, {Peter O.} and Lanar, {David E.} and Min, {Xinan M.} and Kazura, {James W.}",
year = "2008",
month = "2",
day = "15",
doi = "10.1086/526787",
language = "English (US)",
volume = "197",
pages = "519--526",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - Antibodies to pre-erythrocytic Plasmodium falciparum antigens and risk of clinical malaria in Kenyan children

AU - John, Chandy

AU - Tande, Aaron J.

AU - Moormann, Ann M.

AU - Sumba, Peter O.

AU - Lanar, David E.

AU - Min, Xinan M.

AU - Kazura, James W.

PY - 2008/2/15

Y1 - 2008/2/15

N2 - Background. IgG antibodies to pre-erythrocytic antigens are involved in prevention of infection and disease in animal models of malaria but have not been associated with protection against disease in human malaria. Methods. Levels of IgG antibodies to circumsporozoite protein (CSP), liver-stage antigen type 1 (LSA-1), and thrombospondin-related adhesive protein (TRAP) were measured in 86 children in a malaria-holoendemic area of Kenya. The children were then monitored for episodes of clinical malaria for 52 weeks. Results. Children with high levels of IgG antibodies to CSP, LSA-1, and TRAP had a decreased risk of clinical malaria (adjusted hazard ratio, 0.29; 95% confidence interval 0.10-0.81; P = .02), a lower incidence of clinical malaria (P = .006), protection from clinical malaria with a parasite level of ≥4000 parasites/μL (P = .03), and a higher hemoglobin level at enrollment (P = .009), compared with children with lower antibody levels. Protection against malaria morbidity was associated primarily with antibodies to CSP and LSA-1. Conclusions. Kenyan children with high levels of IgG antibodies to the pre-erythrocytic antigens CSP, LSA-1, and TRAP have a lower risk of developing clinical malaria than children without high levels of these antibodies. The decreased risk of clinical malaria may be mediated in part by prevention of high-density parasitemia.

AB - Background. IgG antibodies to pre-erythrocytic antigens are involved in prevention of infection and disease in animal models of malaria but have not been associated with protection against disease in human malaria. Methods. Levels of IgG antibodies to circumsporozoite protein (CSP), liver-stage antigen type 1 (LSA-1), and thrombospondin-related adhesive protein (TRAP) were measured in 86 children in a malaria-holoendemic area of Kenya. The children were then monitored for episodes of clinical malaria for 52 weeks. Results. Children with high levels of IgG antibodies to CSP, LSA-1, and TRAP had a decreased risk of clinical malaria (adjusted hazard ratio, 0.29; 95% confidence interval 0.10-0.81; P = .02), a lower incidence of clinical malaria (P = .006), protection from clinical malaria with a parasite level of ≥4000 parasites/μL (P = .03), and a higher hemoglobin level at enrollment (P = .009), compared with children with lower antibody levels. Protection against malaria morbidity was associated primarily with antibodies to CSP and LSA-1. Conclusions. Kenyan children with high levels of IgG antibodies to the pre-erythrocytic antigens CSP, LSA-1, and TRAP have a lower risk of developing clinical malaria than children without high levels of these antibodies. The decreased risk of clinical malaria may be mediated in part by prevention of high-density parasitemia.

UR - http://www.scopus.com/inward/record.url?scp=40049102809&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40049102809&partnerID=8YFLogxK

U2 - 10.1086/526787

DO - 10.1086/526787

M3 - Article

C2 - 18275273

AN - SCOPUS:40049102809

VL - 197

SP - 519

EP - 526

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 4

ER -